The Glycated Albumin Assay Landscape: Trends, Challenges, and Market Trajectories
The global glycated albumin assay market is projected to experience robust growth in the coming years, escalating from $0.2 billion in 2023 to $0.3 billion by 2028. This upward trajectory, with a projected compound annual growth rate (CAGR) of 8.9%, can be attributed to several key driving forces. Foremost among these is the alarming rise in the prevalence of diabetes worldwide. As this chronic metabolic disorder becomes increasingly widespread, the demand for accurate diagnostic tools, such as glycated albumin assays, is experiencing a corresponding surge. These assays play a crucial role in monitoring and managing diabetes by measuring the glycated portion of albumin in the blood, providing valuable insights into long-term glycemic control. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=265553363 Additionally, governmental initiatives aimed at promoting disease diagnosis and raising awareness about diabetes management are contributing to the m...